img

Global Chronic Pain Management Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Chronic Pain Management Drugs Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Chronic Pain Management Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chronic Pain Management Drugs market research.
Key companies engaged in the Chronic Pain Management Drugs industry include Pfizer Inc., Depomed Inc., Endo International plc., Purdue Pharma L.P., Novartis AG, AstraZeneca plc., Johnson and Johnson Services Inc., Merck & Co. and Abbott Laboratories, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Chronic Pain Management Drugs were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Chronic Pain Management Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chronic Pain Management Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer Inc.
Depomed Inc.
Endo International plc.
Purdue Pharma L.P.
Novartis AG
AstraZeneca plc.
Johnson and Johnson Services Inc.
Merck & Co.
Abbott Laboratories
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Opioids
Non-narcotic Analgesic
Others

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chronic Pain Management Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Pain Management Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Opioids
1.2.3 Non-narcotic Analgesic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chronic Pain Management Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Pain Management Drugs Market Perspective (2018-2034)
2.2 Chronic Pain Management Drugs Growth Trends by Region
2.2.1 Global Chronic Pain Management Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Chronic Pain Management Drugs Historic Market Size by Region (2018-2023)
2.2.3 Chronic Pain Management Drugs Forecasted Market Size by Region (2024-2034)
2.3 Chronic Pain Management Drugs Market Dynamics
2.3.1 Chronic Pain Management Drugs Industry Trends
2.3.2 Chronic Pain Management Drugs Market Drivers
2.3.3 Chronic Pain Management Drugs Market Challenges
2.3.4 Chronic Pain Management Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Pain Management Drugs Players by Revenue
3.1.1 Global Top Chronic Pain Management Drugs Players by Revenue (2018-2023)
3.1.2 Global Chronic Pain Management Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Chronic Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Pain Management Drugs Revenue
3.4 Global Chronic Pain Management Drugs Market Concentration Ratio
3.4.1 Global Chronic Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Pain Management Drugs Revenue in 2024
3.5 Chronic Pain Management Drugs Key Players Head office and Area Served
3.6 Key Players Chronic Pain Management Drugs Product Solution and Service
3.7 Date of Enter into Chronic Pain Management Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Pain Management Drugs Breakdown Data by Type
4.1 Global Chronic Pain Management Drugs Historic Market Size by Type (2018-2023)
4.2 Global Chronic Pain Management Drugs Forecasted Market Size by Type (2024-2034)
5 Chronic Pain Management Drugs Breakdown Data by Application
5.1 Global Chronic Pain Management Drugs Historic Market Size by Application (2018-2023)
5.2 Global Chronic Pain Management Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Chronic Pain Management Drugs Market Size (2018-2034)
6.2 North America Chronic Pain Management Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Chronic Pain Management Drugs Market Size by Country (2018-2023)
6.4 North America Chronic Pain Management Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Pain Management Drugs Market Size (2018-2034)
7.2 Europe Chronic Pain Management Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Chronic Pain Management Drugs Market Size by Country (2018-2023)
7.4 Europe Chronic Pain Management Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Management Drugs Market Size (2018-2034)
8.2 Asia-Pacific Chronic Pain Management Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Pain Management Drugs Market Size (2018-2034)
9.2 Latin America Chronic Pain Management Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Chronic Pain Management Drugs Market Size by Country (2018-2023)
9.4 Latin America Chronic Pain Management Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Management Drugs Market Size (2018-2034)
10.2 Middle East & Africa Chronic Pain Management Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Chronic Pain Management Drugs Introduction
11.1.4 Pfizer Inc. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.1.5 Pfizer Inc. Recent Development
11.2 Depomed Inc.
11.2.1 Depomed Inc. Company Detail
11.2.2 Depomed Inc. Business Overview
11.2.3 Depomed Inc. Chronic Pain Management Drugs Introduction
11.2.4 Depomed Inc. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.2.5 Depomed Inc. Recent Development
11.3 Endo International plc.
11.3.1 Endo International plc. Company Detail
11.3.2 Endo International plc. Business Overview
11.3.3 Endo International plc. Chronic Pain Management Drugs Introduction
11.3.4 Endo International plc. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.3.5 Endo International plc. Recent Development
11.4 Purdue Pharma L.P.
11.4.1 Purdue Pharma L.P. Company Detail
11.4.2 Purdue Pharma L.P. Business Overview
11.4.3 Purdue Pharma L.P. Chronic Pain Management Drugs Introduction
11.4.4 Purdue Pharma L.P. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.4.5 Purdue Pharma L.P. Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Chronic Pain Management Drugs Introduction
11.5.4 Novartis AG Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.5.5 Novartis AG Recent Development
11.6 AstraZeneca plc.
11.6.1 AstraZeneca plc. Company Detail
11.6.2 AstraZeneca plc. Business Overview
11.6.3 AstraZeneca plc. Chronic Pain Management Drugs Introduction
11.6.4 AstraZeneca plc. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.6.5 AstraZeneca plc. Recent Development
11.7 Johnson and Johnson Services Inc.
11.7.1 Johnson and Johnson Services Inc. Company Detail
11.7.2 Johnson and Johnson Services Inc. Business Overview
11.7.3 Johnson and Johnson Services Inc. Chronic Pain Management Drugs Introduction
11.7.4 Johnson and Johnson Services Inc. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.7.5 Johnson and Johnson Services Inc. Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Detail
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Chronic Pain Management Drugs Introduction
11.8.4 Merck & Co. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.8.5 Merck & Co. Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Detail
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Chronic Pain Management Drugs Introduction
11.9.4 Abbott Laboratories Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.9.5 Abbott Laboratories Recent Development
11.10 GlaxoSmithKline plc.
11.10.1 GlaxoSmithKline plc. Company Detail
11.10.2 GlaxoSmithKline plc. Business Overview
11.10.3 GlaxoSmithKline plc. Chronic Pain Management Drugs Introduction
11.10.4 GlaxoSmithKline plc. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.10.5 GlaxoSmithKline plc. Recent Development
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Chronic Pain Management Drugs Business (2018-2023)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Chronic Pain Management Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Opioids
Table 3. Key Players of Non-narcotic Analgesic
Table 4. Key Players of Others
Table 5. Global Chronic Pain Management Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Chronic Pain Management Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Chronic Pain Management Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Chronic Pain Management Drugs Market Share by Region (2018-2023)
Table 9. Global Chronic Pain Management Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Chronic Pain Management Drugs Market Share by Region (2024-2034)
Table 11. Chronic Pain Management Drugs Market Trends
Table 12. Chronic Pain Management Drugs Market Drivers
Table 13. Chronic Pain Management Drugs Market Challenges
Table 14. Chronic Pain Management Drugs Market Restraints
Table 15. Global Chronic Pain Management Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Chronic Pain Management Drugs Market Share by Players (2018-2023)
Table 17. Global Top Chronic Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Management Drugs as of 2024)
Table 18. Ranking of Global Top Chronic Pain Management Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Chronic Pain Management Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Pain Management Drugs Product Solution and Service
Table 22. Date of Enter into Chronic Pain Management Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Pain Management Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Chronic Pain Management Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Chronic Pain Management Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Chronic Pain Management Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Chronic Pain Management Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Chronic Pain Management Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Chronic Pain Management Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Chronic Pain Management Drugs Revenue Market Share by Application (2024-2034)
Table 32. North America Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Chronic Pain Management Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Chronic Pain Management Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Chronic Pain Management Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Chronic Pain Management Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Chronic Pain Management Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Chronic Pain Management Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Chronic Pain Management Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Chronic Pain Management Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Chronic Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Chronic Pain Management Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. Pfizer Inc. Company Detail
Table 48. Pfizer Inc. Business Overview
Table 49. Pfizer Inc. Chronic Pain Management Drugs Product
Table 50. Pfizer Inc. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 51. Pfizer Inc. Recent Development
Table 52. Depomed Inc. Company Detail
Table 53. Depomed Inc. Business Overview
Table 54. Depomed Inc. Chronic Pain Management Drugs Product
Table 55. Depomed Inc. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 56. Depomed Inc. Recent Development
Table 57. Endo International plc. Company Detail
Table 58. Endo International plc. Business Overview
Table 59. Endo International plc. Chronic Pain Management Drugs Product
Table 60. Endo International plc. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 61. Endo International plc. Recent Development
Table 62. Purdue Pharma L.P. Company Detail
Table 63. Purdue Pharma L.P. Business Overview
Table 64. Purdue Pharma L.P. Chronic Pain Management Drugs Product
Table 65. Purdue Pharma L.P. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 66. Purdue Pharma L.P. Recent Development
Table 67. Novartis AG Company Detail
Table 68. Novartis AG Business Overview
Table 69. Novartis AG Chronic Pain Management Drugs Product
Table 70. Novartis AG Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 71. Novartis AG Recent Development
Table 72. AstraZeneca plc. Company Detail
Table 73. AstraZeneca plc. Business Overview
Table 74. AstraZeneca plc. Chronic Pain Management Drugs Product
Table 75. AstraZeneca plc. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 76. AstraZeneca plc. Recent Development
Table 77. Johnson and Johnson Services Inc. Company Detail
Table 78. Johnson and Johnson Services Inc. Business Overview
Table 79. Johnson and Johnson Services Inc. Chronic Pain Management Drugs Product
Table 80. Johnson and Johnson Services Inc. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 81. Johnson and Johnson Services Inc. Recent Development
Table 82. Merck & Co. Company Detail
Table 83. Merck & Co. Business Overview
Table 84. Merck & Co. Chronic Pain Management Drugs Product
Table 85. Merck & Co. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 86. Merck & Co. Recent Development
Table 87. Abbott Laboratories Company Detail
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Chronic Pain Management Drugs Product
Table 90. Abbott Laboratories Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 91. Abbott Laboratories Recent Development
Table 92. GlaxoSmithKline plc. Company Detail
Table 93. GlaxoSmithKline plc. Business Overview
Table 94. GlaxoSmithKline plc. Chronic Pain Management Drugs Product
Table 95. GlaxoSmithKline plc. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 96. GlaxoSmithKline plc. Recent Development
Table 97. Teva Pharmaceutical Industries Ltd. Company Detail
Table 98. Teva Pharmaceutical Industries Ltd. Business Overview
Table 99. Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Product
Table 100. Teva Pharmaceutical Industries Ltd. Revenue in Chronic Pain Management Drugs Business (2018-2023) & (US$ Million)
Table 101. Teva Pharmaceutical Industries Ltd. Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Pain Management Drugs Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Chronic Pain Management Drugs Market Share by Type: 2024 VS 2034
Figure 3. Opioids Features
Figure 4. Non-narcotic Analgesic Features
Figure 5. Others Features
Figure 6. Global Chronic Pain Management Drugs Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global Chronic Pain Management Drugs Market Share by Application: 2024 VS 2034
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Chronic Pain Management Drugs Report Years Considered
Figure 12. Global Chronic Pain Management Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Chronic Pain Management Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Chronic Pain Management Drugs Market Share by Region: 2024 VS 2034
Figure 15. Global Chronic Pain Management Drugs Market Share by Players in 2024
Figure 16. Global Top Chronic Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Management Drugs as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Pain Management Drugs Revenue in 2024
Figure 18. North America Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Chronic Pain Management Drugs Market Share by Country (2018-2034)
Figure 20. United States Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Chronic Pain Management Drugs Market Share by Country (2018-2034)
Figure 24. Germany Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Chronic Pain Management Drugs Market Share by Region (2018-2034)
Figure 32. China Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Chronic Pain Management Drugs Market Share by Country (2018-2034)
Figure 40. Mexico Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Chronic Pain Management Drugs Market Share by Country (2018-2034)
Figure 44. Turkey Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Chronic Pain Management Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Pfizer Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 47. Depomed Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 48. Endo International plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 49. Purdue Pharma L.P. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 50. Novartis AG Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 51. AstraZeneca plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 52. Johnson and Johnson Services Inc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 53. Merck & Co. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 54. Abbott Laboratories Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 55. GlaxoSmithKline plc. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Chronic Pain Management Drugs Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed